Roka BioScience, Inc. 4
4 · Roka BioScience, Inc. · Filed Nov 10, 2016
Insider Transaction Report
Form 4
Boesgaard Lars
Vice President, CFO
Transactions
- Conversion
Common Stock, $0.001 par value per share
2016-11-10$7.00/sh+3,572$25,004→ 8,938 total - Conversion
Series A Convertible Preferred Stock
2016-11-10−25→ 0 total→ Common stock, par value $0.001 per share (3,572 underlying)
Footnotes (2)
- [F1]Reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the "Series A Preferred Shares") automatically converted into shares of the Company's common stock, par value $0.001 (the "Common Shares") at a conversion price of $7.00 per share resulting in his acquisition of 3,572 Common Shares. Common Shares disclosed reflect the October 11, 2016, 10 for 1 reverse stock split of the Company's Common Shares. The Series A Preferred Shares were adjusted proportionately and consequently, each share of Preferred Stock became convertible into approximately 143 shares of common stock.
- [F2]The Series A Preferred Shares automatically converted, upon receipt of Company shareholder approval and had no expiration date.